THERMALENS is . . .
FDA Cleared
Non-Invasive
Revolutionizing Early Detection
Digital Infrared Imaging System
Why Providers Choose ThermaLens™
Non-Invasive & Radiation-Free — Safe for all patients, including pregnant women
AI Precision — Detects minute thermal changes before structural anomalies form
FDA, CE & CFDA Approved — Globally trusted and rigorously certified
Versatile Across Disciplines — Use in general medicine, neurology, oncology, sports medicine, vascular health, women’s health, and more
Enhance Patient Outcomes: Detect physiological changes earlier, tailor interventions faster.
Expand Clinical Offerings: Serve preventative care, chronic condition management, and wellness-focused patients.
Improve Patient Engagement: Use visible thermal patterns to educate and motivate patients.
Boost ROI: Add a reimbursable, high-impact technology that increases new patient acquisition and retention.
ThermaLens™ Key Features & Technical Highlights
Automatic ROI Detection & Thermal Pattern Identification
Pain Drawing Overlay for Patient Engagement
Clinical Positioning & Protocols for 53+ Conditions
Digital Zoom & Auto Focusing
Motorized Stand with 360° Rotatable Camera Head
High-Resolution IR Imaging (640×480)
Ambient Temperature Compensation for Accuracy
Real-Time Recording and PACS Integration
Clinical Applications for ThermaLens™
Breast abnormalities (especially effective for dense breast tissue)
Rheumatoid arthritis and musculoskeletal inflammation
Vascular blockages, PAD, and DVT
Skin lesions, infections, and wound healing
Neurological conditions including CRPS and facial palsy
Dry eye syndrome and ocular inflammation
Sports injuries and fatigue monitoring
Fever and infection screening
Diabetic foot ulcers
The Science Behind ThermaLens™
A comprehensive white paper, “The Efficacy and Usefulness of Thermal Imaging in Medical Diagnostics” (Maunu, 2024), details over 20 application areas supported by peer-reviewed studies, with demonstrated sensitivities of 80–97% in early-stage disease detection across multiple specialties.
Breast cancer: 96.7% sensitivity (Roslidar et al.)
Diabetic foot ulcers: Early detection of ulcer risk via temperature gradients (Hazenberg et al.)
Rheumatoid arthritis: 96% sensitivity / 92% specificity (Frize et al.)
Want to geek out on the details?
Check out our Toolbox that provides detailed documentation